Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Galenica is a leading Swiss company specialising in the wholesale distribution of drugs and druggists' sundries, with its headquarters based in Switzerland. Established in 1927, the company has built a strong reputation within the pharmaceutical industry, serving pharmacies, hospitals, and healthcare providers across Switzerland and beyond.
Operating within the drugs and druggists' sundries merchant wholesaler sector, Galenica’s core offerings include a comprehensive range of pharmaceuticals, medical supplies, and healthcare products. Its commitment to quality and innovation has positioned it as a key player in the Swiss healthcare supply chain, supporting the efficient delivery of essential medicines. With a history of steady growth and notable achievements, Galenica continues to uphold its status as a trusted leader in pharmaceutical wholesale distribution.
+49 vs industry average
Galenica’s score of 72 is higher than 93% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Drugs and Druggists' Sundries Merchant Wholesalers has typical carbon intensity
The Drugs and Druggists' Sundries Merchant Wholesalers industry has reduced its overall emissions by 35% since 2018
Scope 3 accounts for ••• of total emissions.
Galenica, a "Drugs and Druggists' Sundries Merchant Wholesalers" company headquartered in Switzerland, reported its total carbon emissions for 2025 as approximately 401 million kg CO2e. This includes about 4.85 million kg CO2e from Scope 1, 171,000 kg CO2e from Scope 2 (market-based), and 396.4 million kg CO2e from Scope 3 emissions. For 2024, total emissions were around 384.1 million kg CO2e, with Scope 1 at about 5.15 million kg CO2e, Scope 2 (market-based) at 283,000 kg CO2e, and Scope 3 at approximately 378.7 million kg CO2e. In 2023, total emissions were approximately 381.9 million kg CO2e, comprising about 5.87 million kg CO2e from Scope 1, 1.04 million kg CO2e from Scope 2 (market-based), and 374 million kg CO2e from Scope 3.
Galenica has committed to reducing its operational greenhouse gas emissions (Scope 1 and 2) by 25% by 2025 and by 50% by 2030, using a 2021 base year. The company has also committed to achieving net-zero emissions by 2050, in line with Switzerland's national climate targets. Furthermore, Galenica has set Science-Based Targets initiative (SBTi) commitments to reduce absolute Scope 1 and 2 GHG emissions by 65.55% by 2035 from a 2023 base year. Additionally, Galenica aims for 73.42% of its suppliers, by emissions covering purchased goods and services and upstream transportation and distribution, to have science-based targets by 2030.
2035
65.55% reduction in Scope 2
Galenica commits to reduce absolute scope 1 and 2 GHG emissions 65.55% by 2035 from a 2023 base year.
2035
65.55% reduction in Scope 1
Galenica commits to reduce absolute scope 1 and 2 GHG emissions 65.55% by 2035 from a 2023 base year.
2030
Galenica also commits that 73
Galenica also commits that 73.42% of its suppliers by emissions covering purchased goods and services and upstream transportation and distri…
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
See all scope 3 categories
Already have an account? Sign in now


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Common questions about Galenica’s sustainability data and climate commitments
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more